Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Clear-cell metastatic renal cell carcinoma × belzutifan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 6 Kidney Neoplasms 4 Neoplasm Metastasis 2 Glioblastoma 1 Clear-cell metastatic renal cell carcinoma 1

Interventions

Nivolumab 4 Ipilimumab 4 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 CTLA-4 Antigen 3 Sunitinib 2 pembrolizumab 1 pazopanib 1 fludarabine 1 cabozantinib 1 belzutifan 1 atezolizumab 1 aldesleukin 1 Immunoglobulin G 1 Cyclophosphamide 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07179770 2025-09-23

Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)

NYU Langone Health

Phase 1 Recruiting

Clear-cell metastatic renal cell carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡